The computational predictions were complemented by the in vitro investigations where SBLJ23 effectively inhibited JAK2 in cell-free and cell-based experiments along with apoptotic induction by cell cycle arrest in MPN cells. Here, JAK2 is linked to myeloproliferative disorder.